Julia A. Haller, MD, ophthalmologist-in-chief at Wills Eye Hospital, has been named CEO, succeeding Joseph P. Bilson, ...

Nicotine ingestions among young children declined 2015, but nicotine pouch ingestions more than 700% 2020, according to a ...

Commonly used sulfonylureas were associated with an up to 13% increase in risk for major adverse CV events vs.

Long-acting lenacapavir has been shown to be a promising option for HIV PrEP and is now recommended globally by WHO, with a ...

Nephrology has added a number of new training positions to the field in recent years, but interest has not kept pace. A study ...

In this video, Nancy U. Lin, MD, discusses curative intent research in HER2-positive metastatic breast cancer.

Entering into partnerships with medical and nonmedical organizations in low-to-middle income countries, particularly Kenya and the Philippines, may be a path toward improving outcomes in migraine, ...

In this video, Nancy U. Lin, MD, highlights practice-changing trials in the HER2-positive metastatic breast cancer space.

There was a lot of excitement when Tepezza became the first drug approved for the treatment of thyroid eye disease in January ...

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

Editor’s note: This is an automatically generated transcript. Please notify [email protected] if there are concerns regarding accuracy of the transcription.

A high dose of centanafadine was shown to be safe and effective at lowering ADHD symptoms for adolescents, according to ...